Partl Richard, Lukasiak Katarzyna, Stranz Bettina, Hassler Eva, Magyar Marton, Stranzl-Lawatsch Heidi, Langsenlehner Tanja
Department of Therapeutic Radiology and Oncology, Comprehensive Cancer Center, Medical University of Graz, 8036 Graz, Austria.
Division of Neuroradiology, Vascular and Interventional Radiology, Comprehensive Cancer Center Graz (CCC), Medical University of Graz, Auenbruggerplatz 9, 8036 Graz, Austria.
Diagnostics (Basel). 2021 May 25;11(6):946. doi: 10.3390/diagnostics11060946.
There is evidence suggesting that pre-treatment clinical parameters can predict the probability of sphincter-preserving surgery in rectal cancer; however, to date, data on the predictive role of inflammatory parameters on the sphincter-preservation rate are not available. The aim of the present cohort study was to investigate the association between inflammation-based parameters and the sphincter-preserving surgery rate in patients with low-lying locally advanced rectal cancer (LARC). A total of 848 patients with LARC undergoing radiotherapy from 2004 to 2019 were retrospectively reviewed in order to identify patients with rectal cancer localized ≤6 cm from the anal verge, treated with neo-adjuvant radiochemotherapy (nRCT) and subsequent surgery. Univariable and multivariable analyses were used to investigate the role of pre-treatment inflammatory parameters, including the C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the prediction of sphincter preservation. A total of 363 patients met the inclusion criteria; among them, 210 patients (57.9%) underwent sphincter-preserving surgery, and in 153 patients (42.1%), an abdominoperineal rectum resection was performed. Univariable analysis showed a significant association of the pre-treatment CRP value (OR = 2.548, 95% CI: 1.584-4.097, < 0.001) with sphincter preservation, whereas the pre-treatment NLR (OR = 1.098, 95% CI: 0.976-1.235, = 0.120) and PLR (OR = 1.002, 95% CI: 1.000-1.005, = 0.062) were not significantly associated with the type of surgery. In multivariable analysis, the pre-treatment CRP value (OR = 2.544; 95% CI: 1.314-4.926; = 0.006) was identified as an independent predictive factor for sphincter-preserving surgery. The findings of the present study suggest that the pre-treatment CRP value represents an independent parameter predicting the probability of sphincter-preserving surgery in patients with low-lying LARC.
有证据表明,治疗前的临床参数可以预测直肠癌保肛手术的可能性;然而,迄今为止,关于炎症参数对保肛率预测作用的数据尚不可得。本队列研究的目的是调查低位局部晚期直肠癌(LARC)患者基于炎症的参数与保肛手术率之间的关联。对2004年至2019年期间接受放疗的848例LARC患者进行了回顾性分析,以确定距肛缘≤6 cm的直肠癌患者,这些患者接受了新辅助放化疗(nRCT)及后续手术。采用单因素和多因素分析来研究治疗前炎症参数,包括C反应蛋白(CRP)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对保肛的预测作用。共有363例患者符合纳入标准;其中,210例患者(57.9%)接受了保肛手术,153例患者(42.1%)进行了腹会阴直肠切除术。单因素分析显示,治疗前CRP值(OR = 2.548,95%CI:1.584 - 4.097,< 0.001)与保肛显著相关,而治疗前NLR(OR = 1.098,95%CI:0.976 - 1.235,= 0.120)和PLR(OR = 1.002,95%CI:1.000 - 1.005,= 0.062)与手术类型无显著关联。多因素分析中,治疗前CRP值(OR = 2.544;95%CI:1.314 - 4.926;= 0.006)被确定为保肛手术独立预测因素。本研究结果表明,治疗前CRP值是预测低位LARC患者保肛手术可能性的独立参数。